184 related articles for article (PubMed ID: 7838148)
1. The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.
Archer TK; Zaniewski E; Moyer ML; Nordeen SK
Mol Endocrinol; 1994 Sep; 8(9):1154-62. PubMed ID: 7838148
[TBL] [Abstract][Full Text] [Related]
2. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states.
Smith CL; Wolford RG; O'Neill TB; Hager GL
Mol Endocrinol; 2000 Jul; 14(7):956-71. PubMed ID: 10894147
[TBL] [Abstract][Full Text] [Related]
3. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
Deroo BJ; Archer TK
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
[TBL] [Abstract][Full Text] [Related]
4. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
[TBL] [Abstract][Full Text] [Related]
5. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
Härtig E; Cato AC
Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
[TBL] [Abstract][Full Text] [Related]
6. A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line.
Nordeen SK; Kühnel B; Lawler-Heavner J; Barber DA; Edwards DP
Mol Endocrinol; 1989 Aug; 3(8):1270-8. PubMed ID: 2550815
[TBL] [Abstract][Full Text] [Related]
7. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
[TBL] [Abstract][Full Text] [Related]
8. CBP recruitment and histone acetylation in differential gene induction by glucocorticoids and progestins.
Lambert JR; Nordeen SK
Mol Endocrinol; 2003 Jun; 17(6):1085-94. PubMed ID: 12637584
[TBL] [Abstract][Full Text] [Related]
9. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
[TBL] [Abstract][Full Text] [Related]
10. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter.
Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL
Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066
[TBL] [Abstract][Full Text] [Related]
11. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.
Mymryk JS; Berard D; Hager GL; Archer TK
Mol Cell Biol; 1995 Jan; 15(1):26-34. PubMed ID: 7799933
[TBL] [Abstract][Full Text] [Related]
13. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
[TBL] [Abstract][Full Text] [Related]
14. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Archer TK
Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
[TBL] [Abstract][Full Text] [Related]
15. Nuclear factor I acts as a transcription factor on the MMTV promoter but competes with steroid hormone receptors for DNA binding.
Brüggemeier U; Rogge L; Winnacker EL; Beato M
EMBO J; 1990 Jul; 9(7):2233-9. PubMed ID: 2162764
[TBL] [Abstract][Full Text] [Related]
16. Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter.
Lee HL; Archer TK
EMBO J; 1998 Mar; 17(5):1454-66. PubMed ID: 9482742
[TBL] [Abstract][Full Text] [Related]
17. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
[TBL] [Abstract][Full Text] [Related]
18. Extreme position dependence of a canonical hormone response element.
Nordeen SK; Ogden CA; Taraseviciene L; Lieberman BA
Mol Endocrinol; 1998 Jun; 12(6):891-8. PubMed ID: 9626664
[TBL] [Abstract][Full Text] [Related]
19. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
[TBL] [Abstract][Full Text] [Related]
20. The hormone responsive region of mouse mammary tumor virus positions a nucleosome and precludes access of nuclear factor I to the promoter.
Candau R; Chávez S; Beato M
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):19-31. PubMed ID: 8645614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
